logo

Global Viral Clearance Services Market Size (2024 - 2029)

The viral clearance services market is experiencing significant growth, driven by the increasing demand for viral clearance and specialty drugs. The market's expansion is further influenced by the heightened need for viral clearance studies, which are essential for regulatory submissions in biopharmaceuticals. These studies, often conducted at specialized contract laboratories, are crucial for ensuring the safety of biological and biotechnological products by mitigating the risk of viral contamination. The impact of COVID-19 has also played a role in amplifying the demand for these services, as the pandemic underscored the importance of effective viral clearance processes.

Home Market Analysis Healthcare Research Health Services Research Laboratory Services Research Global Viral Clearance Services Market Market Size

Market Size of Global Viral Clearance Services Industry

Viral Clearance Services Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 15.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Viral Clearance Services Market Analysis

The viral Clearance Services Market is Poised to grow at a CAGR of 15% over the forecast period. The major factors attributing to the growth of the market are the rising need for viral clearance and the increasing demand for specialty drugs

COVID-19 has a significant impact on the market studied. During COVID-19, the isolation of patients was the priority across the globe. A study published in the Journal of Infection and Chemotherapy in June 2021 stated that a classification of the isolation times based on age could be taken into consideration while processing the viral clearance since the length of the viral clearance periods from COVID-19 patients can vary with age. Due to biases including underlying medical disorders, it may be challenging to establish a uniform viral clearance duration for elderly patients. With the increased incidence of COVID-19, the demand for viral clearance was raised which contributed to the growth of the market.

Viral clearance studies are a necessary component of any regulatory submission for clinical trials or approval of all biopharmaceutical products. These studies are performed to evaluate the capability of the purification process to remove inactivated viruses that could potentially contaminate the starting material. They are complex studies that require substantial financial and personnel resources, as well as specialized scientific expertise. As such, viral clearance studies are often performed at a qualified contract testing laboratory rather than in-house.

Biological and biotechnological products are at risk from impurities, bacteria and fungi, and viruses. With such products, the potential for transmission of viral diseases is a real risk. Viral contamination can affect raw materials, cell culture processes, bioreactor contamination, and downstream processing. It is for these reasons that pharmaceutical organizations practice viral safety and incorporate virus clearance into the manufacturing process.

Viral Clearance Services Industry Segmentation

As per the scope of the report viral clearance services include the removal of viruses or bacteria that have been unintentionally left behind on the production equipment and biological products. These services include testing the end-products and equipment for any viruses and ensuring in safe and consistent development of biological products. The Viral Clearance Services Market is segmented by Method (Viral Removal, Viral Inactivation), Application (Recombinant Proteins, Tissue & Blood-Derived Products, Vaccines, Others), by End-User (Biopharmaceuticals, Contract Research Organizations, Academic Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Method
Viral Removal
Viral Inactivation
By Application
Recombinant Proteins
Tissue and Blood Derived Products
Vaccines
Others
By End-User
Biopharmaceuticals
Contract Research Organizations
Academic Research Institutes
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Viral Clearance Services Market Size Summary

The viral clearance services market is experiencing significant growth, driven by the increasing need for viral clearance and the rising demand for specialty drugs. This growth is further fueled by the heightened focus on viral safety during the COVID-19 pandemic, which underscored the importance of viral clearance in biopharmaceuticals. Viral clearance studies are essential for regulatory submissions and are conducted to ensure the purification processes can effectively remove inactivated viruses that may contaminate biopharmaceutical products. These studies require substantial resources and expertise, often leading to their execution at specialized contract testing laboratories. The demand for viral clearance services is particularly strong in the production of large-scale recombinant proteins, which are critical for proteomics, structural biology, and protein therapeutics. The increasing production of biopharmaceuticals for chronic conditions and the introduction of recombinant proteins are key factors propelling market growth.

North America is anticipated to dominate the viral clearance services market throughout the forecast period, largely due to the presence of key industry players and advanced medical technologies. The region's growth is supported by the rising production of recombinant proteins and vaccines, necessitating robust viral clearance processes. Additionally, increased funding for pharmaceuticals in the United States is contributing to market expansion, despite potential regulatory challenges aimed at reducing drug costs. The competitive landscape of the viral clearance services market includes major players such as Charles River, Merck KGaA, and WuXi AppTec, among others. Recent developments, such as the opening of new viral clearance laboratories by Merck and Abzena, highlight the ongoing investment and innovation within the industry, further supporting the market's growth trajectory.

Explore More

Global Viral Clearance Services Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Need of Viral Clearance

      2. 1.2.2 Rise in Research and Development Funding

      3. 1.2.3 Growing Demand for Specialty Drugs

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Approval of Outsourcing of Preclinical Procedures

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value in USD million)

    1. 2.1 By Method

      1. 2.1.1 Viral Removal

      2. 2.1.2 Viral Inactivation

    2. 2.2 By Application

      1. 2.2.1 Recombinant Proteins

      2. 2.2.2 Tissue and Blood Derived Products

      3. 2.2.3 Vaccines

      4. 2.2.4 Others

    3. 2.3 By End-User

      1. 2.3.1 Biopharmaceuticals

      2. 2.3.2 Contract Research Organizations

      3. 2.3.3 Academic Research Institutes

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Viral Clearance Services Market Size FAQs

The Global Viral Clearance Services Market is projected to register a CAGR of 15% during the forecast period (2024-2029)

Charles River, Labor Dr. Merk & Kollegen GmbH, Merck KGaA, Texcell and WuXi AppTec are the major companies operating in the Global Viral Clearance Services Market.

Global Viral Clearance Services Report Snapshots

Viral Clearance Services Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)